ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 642321 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 642321; 2) Community: the network communities that were significantly associated with the response to NSC 642321; 3) Molecule: the relationships between components within communities and NSC 642321; 4) MDR: the compounds that were significantly associated with the NSC 642321.

NSC Compound Enrichment Correlation
NSC 742295 (11aS)-8-(5-[4-(1,3-benzothiazol-2-yl)phenoxy]pentyloxy)-7-methoxy-2,3,5,11a-tetrahydro-1H-benzo[e]pyrrolo[1,2-a][1,4]diazepin-5-one 0.0410413740044188 0.2172091
NSC 747253 Trihexyl(tetradecyl)phosphonium Tetrafluoroborate 0.0410413740044188 0.2154446
NSC 750485 [(1H-benzimidazole-2-yl)dithio]-9H-purine 0.0410413740044188 0.15116443
NSC 764135 BMS-599626 0.0410413740044188 -0.10380683
NSC 728134 1-[4-(1-benzyl-4-chloro-2,5-dioxo-2,5-dihydro-1H-3-pyrrolyla mino)phenylcarboxamido]-5-chloro-2-methoxybenzene 0.0410413740044192 0.12796802
NSC 143925 Pekilocerin A 0.0420420371076614 0.11602434
NSC 175633 4(1H)-Quinazolinone, 2-(2-chlorophenyl)-2,3-dihydro- 0.0420420371076614 0.17278155
NSC 293046 Carbamimidothioic acid, (4-oxo-2-phenyl-4H-1-benzopyran-8-yl)methyl ester, monohydrobromide 0.0420420371076614 0.11165298
NSC 295501 Camptothecin Derivative 0.0420420371076614 0.39501422
NSC 373814 Null 0.0420420371076614 0.07793917
Total:55  Current:41    [First] [Prev] [Next] [Last]